BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1671710)

  • 1. Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene.
    Yu DH; Scorsone K; Hung MC
    Mol Cell Biol; 1991 Mar; 11(3):1745-50. PubMed ID: 1671710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
    Yu D; Hamada J; Zhang H; Nicolson GL; Hung MC
    Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products.
    Yu D; Suen TC; Yan DH; Chang LS; Hung MC
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4499-503. PubMed ID: 1972274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
    Ragozzino MM; Kuo A; DeGregori J; Kohl N; Ruley HE
    Environ Health Perspect; 1991 Jun; 93():97-103. PubMed ID: 1837777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of immortalization and T24-ras oncogene cooperative functions of adenovirus E1a.
    Kuppuswamy M; Subramanian T; Chinnadurai G
    Oncogene; 1988 Jun; 2(6):613-5. PubMed ID: 2968534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
    Yu D; Shi D; Scanlon M; Hung MC
    Cancer Res; 1993 Dec; 53(23):5784-90. PubMed ID: 7902209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein.
    White E; Cipriani R
    Mol Cell Biol; 1990 Jan; 10(1):120-30. PubMed ID: 2136765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation.
    Hung MC; Yan DH; Zhao XY
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2545-8. PubMed ID: 2565034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.
    Rao L; Debbas M; Sabbatini P; Hockenbery D; Korsmeyer S; White E
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7742-6. PubMed ID: 1457005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 proto-oncogene can act as a suppressor of transformation.
    Finlay CA; Hinds PW; Levine AJ
    Cell; 1989 Jun; 57(7):1083-93. PubMed ID: 2525423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
    Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells.
    Cook JL; May DL; Wilson BA; Walker TA
    J Virol; 1989 Aug; 63(8):3408-15. PubMed ID: 2526229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
    Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of adenovirus 5 E1A domains responsible for suppression of neu-mediated transformation via transcriptional repression of neu.
    Chen H; Yu D; Chinnadurai G; Karunagaran D; Hung MC
    Oncogene; 1997 Apr; 14(16):1965-71. PubMed ID: 9150363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
    Reardon DB; Hung MC
    J Biol Chem; 1993 Aug; 268(24):18136-42. PubMed ID: 7688739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenes.
    Shalloway D; Johnson PJ; Freed EO; Coulter D; Flood WA
    Mol Cell Biol; 1987 Oct; 7(10):3582-90. PubMed ID: 2446117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus E1a as a tumor-suppressor gene.
    Chinnadurai G
    Oncogene; 1992 Jul; 7(7):1255-8. PubMed ID: 1535700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial reversion of transformed phenotype of B104 cancer cells by antisense nucleic acids.
    Shaw YT; Chang SH; Chiou ST; Chang WC; Lai MD
    Cancer Lett; 1993 Apr; 69(1):27-32. PubMed ID: 8097670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products.
    Yan DH; Chang LS; Hung MC
    Oncogene; 1991 Feb; 6(2):343-5. PubMed ID: 1672040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.